News - BioPharm International



Alvotech Plans Multimillion Biosimilars Investment

December 6, 2013

Alvotech plans investment in biosimilars portfolio and manufacturing facility.

European Medicines Agency Revises Orphan Drugs Policy

December 3, 2013

EMA revises its polices on fee reductions for orphan drugs for 2014.

President Obama Signs Drug Quality and Security Act

December 2, 2013

Drug Quality and Security Act gives FDA authority over compounding pharmacies.

USP and Other Organizations Unite in Campaign to Raise Awareness of Counterfeit Medicines

November 29, 2013

The international “Fight the Fakes” campaign will raise awareness about the dangers of counterfeit medicines.

Merck KGaA Invests in Research Partnerships in Israel

November 27, 2013

Additional companies join Merck KGaA and Neviah Genomics in the Israel BioIncubator.

Lilly Funds Start Up of Biosciences Research Institute

November 27, 2013

The Indiana Biosciences Research Institute will accelerate collaboration and focus on human-health solutions.

Mylan Receives Approval for Biosimilar in India; Reaches Settlement with Teva on Copaxone

November 26, 2013

Mylan and the Indian biopharmaceutical company Biocon receive approval for a biosimilar version of trastuzumab in India. Also, Mylan and Teva reach settlement on Copaxone in the EU.

EC Approves Acquisition of Life Technologies by Thermo Fisher, With Conditions

November 26, 2013

Thermo Fisher must divest of cell culture media and sera lines, and other businesses, in purchase of Life Technologies.

EMA Launches Vaccine Monitoring Project

November 26, 2013

European Medicines Agency announces the launch of the Accelerated development of vaccine benefit-risk collaboration in Europe (ADVANCE) project.



Click here